Scopus Enriches Literature Research With Patent...

AMSTERDAM, September 27 /PRNewswire/ --

    - New Citation Features Provide Additional Insights Into Influence of
Research



    Scopus(R), the world's largest abstract and citation database of research
information and quality Web sources, today announced the launch of two new
features. PatentCites, released to customers on September 22nd, allows users
to track how primary research is practically applied in patents. WebCites,
which is to be launched shortly, is the first step towards enabling Scopus
users to track the influence of peer reviewed research on web literature.



    Researchers want to know the influence of research described in a
published journal article. Influence can be evaluated by how often an article
has been cited in other research articles; however, research influence often
extends beyond the official scholarly literature. For example, how the
article has been used in patents, theses or other "grey literature" often
available on the web.



    Scopus PatentCites clearly identifies citations from patent sources that
cite Scopus articles on the Abstract and References page. Just like article
citation counts, PatentCites links directly to the source items. This unique
feature enables users to immediately see the relationship of primary research
to its practical application in patents and will be of particular value to
those working in disciplines such medicine, engineering, chemistry,
agriculture or other applied sciences.



    Among the key growing number of patent sources covered and updated daily
are the US Patent Office, European Patent Office and the World Intellectual
Property Organization.



    In the forthcoming release of WebCites, users will be able to view
citations to articles in Scopus from a growing number of carefully selected
scientific web sources such as Institutional Repositories and Thesis and
Dissertation databases as well as other carefully selected web sources. Users
will be able to gain additional insights into the influence of specific
articles and place article citation numbers from outside the peer-reviewed
realm into perspective.



    Like PatentCites, WebCites will be presented clearly in a separate
display allowing the user to link directly to the relevant source items
through just one click.



    "Scopus users already enjoy full integration of the scientific Web in the
search results. We have further applied the fundamental strengths of Scopus -
namely the selection of quality and relevant sources, and powerful citation
tracking -" says Scopus Director, Jaco Zijlstra "to disclose the influence of
peer reviewed research literature on online grey literature and patents."



About Scopus

    Covering the world's research literature, Scopus is the largest and
easiest to use navigation tool ever built. Scopus is designed and developed
with over 300 users and librarians internationally. Its unique database
contains abstracts and references from over 15,000 titles from 4,000
different publishers, ensuring broad interdisciplinary coverage. In addition,
Scopus not only offers users citation information about the articles covered,
but also integrates web & patent searches directly from its clean and simple
interface. Direct links to full-text articles, library resources and other
applications like reference management software, make Scopus quicker, easier
and more comprehensive to use than any other literature research tool.



For more information about Scopus please visit www.info.scopus.com.

About Elsevier

    Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in
77offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult 
(http://www.mdconsult.com/), Scopus (http://www.news.scopus.com/),
bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).